Thermo Fisher Scientific Inc. ( NYSE:TMO ) shareholders might be concerned after seeing the share price drop 10% in ...

Thermo Fisher's Q3 numbers just dropped, and while revenue hit $10.60 billion (a slight uptick from Q2), it's flat compared ...

Guion, leader of Thermo Fisher Scientific’s Pride+ BRG, spoke to myGwork about his journey from a closeted boy growing up in the AIDS epidemic, to a confident advocate for the LGBTQ+ community on a ...

The United Nations (UN) has reiterated the need to expedite projected emissions reductions from the use of fossil fuels.

DelveInsight's D-Dimer Testing Market Insights report provides the current and forecast market analysis, individual leading D ...

Investing.com -- Thermo Fisher Scientific Inc., a leading scientific instruments maker, reported third-quarter earnings that surpassed analyst expectations, while revenue fell slightly short of ...

Thermo Fisher Scientific Inc (NYSE:TMO), a leading player in the Life Science Tools & Diagnostics sector, has been navigating a complex market landscape characterized by both challenges and ...

The US Food and Drug Administration granted clearances for various tests for infectious diseases, coagulation disorders, and drug susceptibility.

The global gene editing market is expected to reach USD 7.59 billion in 2029 from USD 4.66 billion in 2024, at a CAGR of 10.2 ...

Alveo Technologies, Inc. (Alveo), a leader in decentralized molecular diagnostics with its proprietary IntelliSense™ platform, today announced the launch of its first animal health diagnostic product, ...

Adaptimmune’s Phase II IGNYTE-ESO trial investigating experimental T cell therapy lete-cel has achieved its primary endpoint.